14.95MMarket Cap
LossP/E TTM
NextCure Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of NextCure Inc is 7.28, ranking 188 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.25, which is -99.19% below the recent high of -0.00 and -341.70% above the recent low of -1.09.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.